| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Apr―24 |
Paid and unpaid productivity losses across 28 European countries due to excess deaths and COVID-19 deaths from 2020 to 2023 |
Paweł Niewiadomski, Marta Ortega-Ortega, Błażej Łyszczarz |
| 2 |
[GO] |
2026―Apr―06 |
Public preferences for saving lives versus life-years: evidence from a person-trade-off experiment in 12 countries during the COVID-19 pandemic |
Fiorella Parra-Mujica, Laurence S. J. Roope, Mara Violato, Raymond M. Duch, Philip M. Clarke |
| 3 |
[GO] |
2026―Mrz―21 |
Non-communicable diseases, COVID-19 and labour market outcomes |
Wasana Kalansooriya, Victoria Serra-Sastre, Mireia Jofre-Bonet |
| 4 |
[GO] |
2026―Jan―21 |
Assessing the costs and benefits of non-pharmaceutical pandemic measures using the economic values of social contacts |
Mortaza Baky Haskuee, Ali Asgary, Zachary McCarthy, Sperydon Koumarianos, Callista Wu, Ali Parsa, et al. (+2) Andrew Fallone, Jianhong Wu |
| 5 |
[GO] |
2026―Jan―12 |
The effect of age-specific stay-at-home recommendation on healthcare utilization: Evidence from Finland’s COVID-19 policy |
Jukka Laaksonen, Mika Kortelainen, Henri Salokangas |
| 6 |
[GO] |
2025―Jul―10 |
Health economic outcomes and national economic impacts associated with Long COVID in England and Scotland |
Joseph Kwon, Joseph Mensah, Ruairidh Milne, Clare Rayner, Román Rocha Lawrence, Johannes De Kock, et al. (+2) Manoj Sivan, Stavros Petrou |
| 7 |
[GO] |
2025―Jun―14 |
Time preferences and COVID-19 vaccination uptake |
Arthur E. Attema, Marcello Antonini, Mesfin Genie, Aleksandra Torbica, Francesco Paolucci |
| 8 |
[GO] |
2024―Jul―27 |
Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19 |
Wenjing Zhou, Yaqin Li, Jan Busschbach, Michael Herdman, Zhihao Yang, Yanming Lu |
| 9 |
[GO] |
2024―Mrz―18 |
From test to rest: evaluating socioeconomic differences along the COVID-19 care pathway in the Netherlands |
Iris Meulman, Ellen Uiters, Mariëlle Cloin, Jeroen Struijs, Johan Polder, Niek Stadhouders |
| 10 |
[GO] |
2024―Feb―29 |
Can redistribution of vaccine improve global welfare? Lessons from COVID-19 |
Gunjan Kumari, Oindrila Dey |
| 11 |
[GO] |
2023―Dez―26 |
Impact of Long COVID on productivity and informal caregiving |
Joseph Kwon, Ruairidh Milne, Clare Rayner, Román Rocha Lawrence, Jordan Mullard, Ghazala Mir, et al. (+3) Brendan Delaney, Manoj Sivan, Stavros Petrou |
| 12 |
[GO] |
2023―Okt―21 |
Correction: Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic |
Sebastian Himmler, Job van Exel, Werner Brouwer, Sebastian Neumann-Böhme, Iryna Sabat, Jonas Schreyögg, et al. (+3) Tom Stargardt, Pedro Pita Barros, Aleksandra Torbica |
| 13 |
[GO] |
2023―Jul―06 |
Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic |
Sebastian Himmler, Job van Exel, Werner Brouwer, Sebastian Neuman-Böhme, Iryna Sabat, Jonas Schreyögg, et al. (+3) Tom Stargardt, Pedro Pita Barros, Aleksandra Torbica |
| 14 |
[GO] |
2023―Jun―17 |
COVID-19 and income inequality in OECD countries: a methodological comment-a reply |
John Wildman |
| 15 |
[GO] |
2023―Feb―23 |
COVID-19 and EQ-5D-5L health state valuation |
Edward J. D. Webb, Paul Kind, David Meads, Adam Martin |
| 16 |
[GO] |
2023―Feb―20 |
Risk, time preferences, trustworthiness and COVID-19 preventive behavior: evidence from France |
Julien Bergeot, Florence Jusot |
| 17 |
[GO] |
2023―Feb―02 |
The trade-off between health system resiliency and efficiency: evidence from COVID-19 in European regions |
Alvaro Almeida |
| 18 |
[GO] |
2023―Jan―19 |
Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany |
Hoa Thi Nguyen, Claudia M. Denkinger, Stephan Brenner, Lisa Koeppel, Lucia Brugnara, Robin Burk, et al. (+4) Michael Knop, Till Bärnighausen, Andreas Deckert, Manuela De Allegri |
| 19 |
[GO] |
2022―Aug―11 |
Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic |
Yi Wang, Nantasit Luangasanatip, Wirichada Pan-ngum, Wanrudee Isaranuwatchai, Juthamas Prawjaeng, Sompob Saralamba, et al. (+3) Christopher Painter, Jamaica Roanne Briones, Yot Teerawattananon |
| 20 |
[GO] |
2022―Aug―02 |
Reducing the basic reproduction number of COVID-19: a model simulation focused on QALYs, hospitalisation, productivity costs and optimal (soft) lockdown |
Jose Robles-Zurita |
| 21 |
[GO] |
2022―Jul―24 |
Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands |
Paul Mark Mitchell, Rachael L. Morton, Mickaël Hiligsmann, Samantha Husbands, Joanna Coast |
| 22 |
[GO] |
2022―Apr―25 |
Vaccination or NPI? A conjoint analysis of German citizens' preferences in the context of the COVID-19 pandemic |
Jacques Bughin, Michele Cincera, Evelyn Kiepfer, Dorota Reykowska, Florian Philippi, Marcin Żyszkiewicz, et al. (+2) Rafal Ohme, Dirk Frank |
| 23 |
[GO] |
2022―Mrz―19 |
The common interests of health protection and the economy: evidence from scenario calculations of COVID-19 containment policies |
Florian Dorn, Sahamoddin Khailaie, Marc Stoeckli, Sebastian C. Binder, Tanmay Mitra, Berit Lange, et al. (+6) Stefan Lautenbacher, Andreas Peichl, Patrizio Vanella, Timo Wollmershäuser, Clemens Fuest, Michael Meyer-Hermann |
| 24 |
[GO] |
2022―Mrz―19 |
Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment |
Jonathan Sicsic, Serge Blondel, Sandra Chyderiotis, François Langot, Judith E. Mueller |
| 25 |
[GO] |
2022―Mrz―09 |
Inequality, public health, and COVID-19: an analysis of the Spanish case by municipalities |
Ignacio Amate-Fortes, Almudena Guarnido-Rueda |
| 26 |
[GO] |
2022―Feb―16 |
Communities and testing for COVID-19 |
Steven Stillman, Mirco Tonin |
| 27 |
[GO] |
2022―Feb―09 |
Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics |
Axel C. Mühlbacher, Andrew Sadler, Yvonne Jordan |
| 28 |
[GO] |
2022―Jan―11 |
COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach |
Matthias Klumpp, Dominic Loske, Silvio Bicciato |
| 29 |
[GO] |
2021―Nov―19 |
Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme |
Danny Wende, Dagmar Hertle, Claudia Schulte, Pedro Ballesteros, Uwe Repschläger |
| 30 |
[GO] |
2021―Nov―11 |
The COVID-19 crisis and telework: a research survey on experiences, expectations and hopes |
Eline Moens, Louis Lippens, Philippe Sterkens, Johannes Weytjens, Stijn Baert |
| 31 |
[GO] |
2021―Nov―09 |
Microeconomics of intertemporal choice in zero-space during Covid-19: a behavioral economics perspective |
Javier Cifuentes-Faura, Renaud Di Francesco |
| 32 |
[GO] |
2021―Nov―06 |
Work ethics, stay-at-home measures and COVID-19 diffusion |
Vincenzo Alfano |
| 33 |
[GO] |
2021―Okt―22 |
Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan |
Eyal Lahav, Shosh Shahrabani, Mosi Rosenboim, Yoshiro Tsutsui |
| 34 |
[GO] |
2021―Aug―21 |
The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study |
Paul Hanly, Michelle Ahern, Linda Sharp, Diana Ursul, Gerard Loughnane |
| 35 |
[GO] |
2021―Aug―04 |
Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy |
Gaetano Perone |
| 36 |
[GO] |
2021―Jul―25 |
Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis |
Amit Summan, Arindam Nandi |
| 37 |
[GO] |
2021―Jul―20 |
Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe? |
Sebastian Himmler, Job van Exel, Werner Brouwer |
| 38 |
[GO] |
2021―Jul―15 |
How the COVID-19 pandemic can distort risk adjustment of health plan payment |
Richard C. van Kleef, Mieke Reuser |
| 39 |
[GO] |
2021―Jul―13 |
COVID-19: not the time for health economists? A plea for more proactive health economic involvement |
J.-Matthias Graf von der Schulenburg |
| 40 |
[GO] |
2021―Jul―08 |
The impact of COVID-19 pandemic on insurance demand: the case of China |
Xianhang Qian |
| 41 |
[GO] |
2021―Jul―05 |
Public health policies for the common interest: rethinking EU states’ incentives strategies when a pandemic reshuffles all interests |
Juan Del Llano, Jorge Mestre-Ferrandiz, Jaime Espin, Jordi Gol-Montserrat, Alicia del Llano, Carlos Bringas |
| 42 |
[GO] |
2021―Mai―06 |
Assessing the consequences of quarantines during a pandemic |
Rikard Forslid, Mathias Herzing |
| 43 |
[GO] |
2021―Mai―03 |
Can the Covid19 pandemic affect the achievement of the ‘Zero Hunger’ goal? Some preliminary reflections |
Donatella Saccone |
| 44 |
[GO] |
2021―Mrz―22 |
Are regions equal in adversity? A spatial analysis of spread and dynamics of COVID-19 in Europe |
Mounir Amdaoud, Giuseppe Arcuri, Nadine Levratto |
| 45 |
[GO] |
2021―Feb―18 |
COVID-19 and income inequality in OECD countries |
John Wildman |
| 46 |
[GO] |
2021―Jan―02 |
COVID-19 and the role of inequality in French regional departments |
Victor Ginsburgh, Glenn Magerman, Ilaria Natali |
| 47 |
[GO] |
2020―Nov―24 |
More room for telemedicine after COVID-19: lessons for primary care? |
Livio Garattini, Marco Badinella Martini, Michele Zanetti |
| 48 |
[GO] |
2020―Jun―26 |
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19 |
Sebastian Neumann-Böhme, Nirosha Elsem Varghese, Iryna Sabat, Pedro Pita Barros, Werner Brouwer, Job van Exel, et al. (+2) Jonas Schreyögg, Tom Stargardt |
| 49 |
[GO] |
2020―Jun―04 |
Historical evidence for economic effects of COVID-19 |
Rahmiye Figen Ceylan, Burhan Ozkan, Esra Mulazimogullari |
| 50 |
[GO] |
2020―Jun―03 |
Modelling Covid-19 under uncertainty: what can we expect? |
Meimei Wang, Steffen Flessa |
